Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

LY900009

Cat. No.: IBDI-432594

LY900009 is a potent and orally active, First-in-class inhibitor of Notch signaling via selective inhibition of the γ-secretase protein (GSI). LY900009 inhibited Notch signalling in tumor cell lines and endothelial cells (IC50 range: 0.005-20 nM). LY900009 can be used for advanced cancer research.

Size (Solid):

Product Details

Target Notch | γ-secretase
Molecular Weight 409.48
SMILES CC(C)[[email protected]](O)C(N[[email protected]@H](C)C(N[[email protected]]1C2=CC=CC=C2C3=CC=CC=C3N(C)C1=O)=O)=O

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.